Home » Newsletters » BioWorld Science

BioWorld Science

April 21, 2004

View Archived Issues

Simple or combined DNA methyltransferase antisense therapy effective against gastric, renal cancer

Effective vascular collapse in vivo by novel microtubule depolymerizing agent

Novel improved NM-3 antiangiogenic analogues designed by Ilex Oncology

R&D highlights from the 3rd Annual Global Biotech Forum for Investing & Partnering: ArQule

R&D highlights from the 3rd Annual Global Biotech Forum for Investing & Partnering: Biocortech

Curcumin alleviates beta-amyloid(1-42)-induced memory deficits

Norepinephrine is necessary for memory retrieval

Therapeutic benefits of controlled-release paroxetine in patients with social phobia

An intensive atorvastatin regimen reported to block progression of coronary atherosclerosis

Regression of atherosclerosis found with ETC-216 in patients with acute coronary syndrome

R&D highlights from the 3rd Annual Global Biotech Forum for Investing & Partnering: Biota

Five series of GnRH antagonists presented by AstraZeneca

Novel calpain inhibitors identified at Senju

Two series of cannabinoid CB2 modulators prepared and tested at GSK

New cathepsin K inhibitors in early development at Novartis

AstraZeneca claims MMP-12 inhibitors with utility in asthma and COPD therapy

Novel PDGFR inhibitors and their use in cancer therapy described in Pfizer patent

Clinical progression of remofovir earns Metabasis milestone

Traditional approval for Ziagen

Phase I trial of TNF-alpha inhibitor in HAART-resistant AIDS patients

Positive preliminary results for Histo-RECAF diagnostic kit

GAD65 gene-manipulated plants prevent diabetes in mice

Seretide Diskus submitted for Japanese approval

Pharming and Esteve to partner on rrecombinant human plasma protease C1 inhibitor

Additional data reported from European phase II trial of FM-VP4

rhThrombin enters phase II

FDA accepts sBLA for Remicade in treatment of ankylosing spondylitis

Series B financing supports efforts at Dynogen

Neoprobe discusses regulatory path forward for RIGS technology with FDA

Discovery Partners International and Vertex enter collaborative agreement

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...